Deal Details

Helios Global Group Is Acquired by Telemos

Healthcare

Helios Global Group, a portfolio company of NorthEdge, sale to Telemos

Summary

Helios Global Group Limited (“Helios Global Group” or "The Group"), a portfolio company of NorthEdge Capital LLP (“NorthEdge”), has announced its next stage investment by Telemos Capital (“Telemos”). Terms of the transaction were not disclosed. The transaction is subject to various regulatory approvals and customary closing conditions.

Baird served as exclusive financial advisor to Helios Global Group on this transaction.

About

Helios Global Group is a full-service healthcare communications group employing almost 300 healthcare communications and market access/HEOR professionals across the UK and USA. The Group works with some of the world’s leading pharmaceutical and biotech clients, supporting them within the medical affairs, commercial and market access functions by providing strategic consultancy, medical and scientific communications and commercialisation solutions. Helios added Cogentia, a health economics and market access company, to the group in February 2024 to expand its service capabilities. The Group is headquartered in Alderley Edge, Cheshire with further UK offices in Oxford, Manchester and Cambridge, alongside an expanding US base in Connecticut.

NorthEdge is a lower mid-market private equity firm that is built by its senior team and supported by a global blue chip investor base. NorthEdge has £900m AUM across four regionally focused funds. The NorthEdge team has a 25-year track record of investing in businesses with ambitious management teams and significant growth potential. Its current portfolio of 27 businesses employs over 8,000 people. NorthEdge looks to invest in like-minded businesses and management teams who have real ambition and the potential to shape global markets. They back management teams, in the Technology, Healthcare, Business Services and Specialised Industrials sectors, who recognise the value of having an experienced business partner alongside them, supporting them to build a better business. NorthEdge is headquartered in Manchester, United Kingdom.

Telemos invests in private European businesses with the aim of building great companies for the long term. Funded by family capital, it combines the flexibility and nimble decision making of a family office with the active ownership and professionalism of private equity. Telemos seeks to acquire majority stakes in healthcare, business services and consumer businesses with the potential for sustainable growth through international expansion, add-on acquisitions and operational improvements. Other Telemos investments in the Healthcare sector include Stingray, Sanoptis (exited in 2022) and MedEuropa (exited in 2024). Telemos is headquartered in London, United Kingdom.

Healthcare

Helios Global Group, a portfolio company of NorthEdge, sale to Telemos